Navigation Links
Genomatix technology facilitates de novo identification of new renal disease associated genes

Previously unknown molecules and regulatory pathways in human glomerular diseases have been identified by a joint effort of the Medizinische Poliklinik, Munich, the University of Bristol´s Children´s Renal Unit, the German Cancer Research Center, sanofi-aventis, and Genomatix Software GmbH.

In a joint publication in the Proceedings of the National Academy of Sciences of the United States of America (PNAS) above groups show how new bioinformatics approaches allow rapid characterization of shared promoter structures which can be used to find novel interacting molecules. Here, these principles are applied to a set of genes linked to the unique functional unit of the glomerular slit diaphragm. An evolutionarily conserved promoter model was generated. Genome-wide scans using this promoter model effectively predicted a previously unrecognized slit diaphragm molecule which was then experimentally verified.

This publication shows a straightforward approach how comparative promoter analysis can identify regulatory pathways at work in tissue homeostasis and disease processes.


'"/>

Source:Genomatix Software GmbH


Page: 1

Related biology news :

1. Genomatix, AAAS ink agreement
2. Genomatix Microarray Analysis Pipeline achieves Affymetrix GeneChip compatible?status
3. MatBase -- A new transcription factor knowledge base released by Genomatix
4. Application of Genomatix in silico methods reveals novel cancer associated genes
5. Novel technology detects human DNA mutations
6. Novel antiviral technology inhibits RSV infection in mice
7. The BIOS Initiative - open source biotechnology is born
8. Revolutionary nanotechnology illuminates brain cells at work
9. Study: homemade gene expression technology unreliable
10. First technology to remove prions that cause vCJD from blood launched
11. Integration of Agilents MS technology, Proteome Systems software to help scientists in proteomics research
Post Your Comments:
(Date:12/11/2013)... as they age and then die, but that,s not the ... signs of aging at all. , These are among the ... journal Nature this week. The study compares the ... "We all have preconceived notions about aging and what it ... the University of Central Florida and one of the contributors ...
(Date:12/11/2013)... French . , ... researchers may pave the way for more effective treatment of ... ETMR/ETANTR. The tumour, which is seen only in children under ... study proposes a new model for how this brain tumour ... These findings, recently published in Nature Genetics , also ...
(Date:12/11/2013)... "ouch" to the chronic and excruciating, has been an ... a promising step toward studying pain in action. In ... American Chemical Society , scientists describe the development of ... could result in better ways to relieve pain and ... Du Bois and colleagues note that current ways to ...
Breaking Biology News(10 mins):Not all species age the same; humans may be outliers 2Canadian researchers lead groundbreaking discovery in deadly childhood cancer 2Canadian researchers lead groundbreaking discovery in deadly childhood cancer 3
... 2009 -- Researchers at Burnham Institute for Medical ... and University of Maryland have demonstrated that an ... be targeted to kill dangerous pathogens. In addition, ... enzyme and suppress the growth of pathogenic bacteria. ...
... landscapes in the National Park of Sierra Nevada (Granada), scientists have ... on holm oak and pine seeds, causing a deterioration of the ... The trees in the forests such as the holm oaks, ... over the mountains. In 98.5% of cases it is field mice ...
... A new policy paper by Rice University,s Baker Institute ... size and influence of noncommercial traders, or "speculators," in ... the Commodities Futures Modernization Act of 2000. Speculators now ... in the U.S. oil futures market, compared with only ...
Cached Biology News:The path to new antibiotics 2Small rodents encourage the formation of scrubland in Spain 2Study: Oil speculators dominate open interest in oil futures 2Study: Oil speculators dominate open interest in oil futures 3
(Date:12/11/2013)... 11, 2013 It is with deepest ... MD. Dr. Dulaney, one of the founding partners of ... changing people’s lives through advanced vision care . ... innovative technology solutions and the potential of individuals. While ... he retired from the practicing in 2006, many patients, ...
(Date:12/10/2013)... December 10, 2013 Tanja Dominko, ... at Worcester Polytechnic Institute (WPI), is the 2013 ... to one Slovenian native each year in recognition ... award also honors Dominko's international engagement in developing ... members with Slovenian colleagues to address important biomedical ...
(Date:12/10/2013)... 2013 According to ... Applications in Risk Assessment, Molecular Diagnostics, Disease ... Forensic Applications and Others) - Global Industry ... Size, Share, Opportunities and Forecast, 2013 - ... global biomarkers market for diagnostic applications such ...
(Date:12/10/2013)... FRANCISCO, Calif. , Dec. 10, 2013 /PRNewswire/ ... development of novel cancer therapeutics, today announced the ... therapeutic candidate, CB-839, at the 55 th ... is a potent, selective, orally available glutaminase inhibitor ... cell growth and survival.  "Glutaminase ...
Breaking Biology Technology:Barnet Dulaney Perkins Eye Center Regrets to Announce the Passing of David Dulaney, MD 2Worcester Polytechnic Institute’s Tanja Dominko Named Slovenian Ambassador of Science for 2013 2Worcester Polytechnic Institute’s Tanja Dominko Named Slovenian Ambassador of Science for 2013 3Worcester Polytechnic Institute’s Tanja Dominko Named Slovenian Ambassador of Science for 2013 4Biomarker Market for Diagnostic Applications is Expected to Reach $30.6 Billion Globally by 2020 - Allied Market Research 2Biomarker Market for Diagnostic Applications is Expected to Reach $30.6 Billion Globally by 2020 - Allied Market Research 3Calithera Biosciences Presents Preclinical Data for CB-839 at the 55th American Society of Hematology Annual Meeting 2
... MNKD ), focused on discovering, developing and,commercializing treatments ... at the UBS Global Life Sciences Conference on September ... Hotel in New York, NY. Interested parties can ... the,presentation in the Investor Relations section of the Company,s ...
... Kosan Biosciences,Incorporated (Nasdaq: KOSN ) announced today ... Financial Officer, will present at the 2007,UBS Global Life ... on,Tuesday, September 25, 2007 at 10:00 a.m. EST. ... presentation by,visiting the "Events Calendar" page under the "Investors/Press" ...
... Results from Preclinical and Clinical Studies Demonstrate Activity ... Investigational Agent against Gram-Positive Bacteria, ... and,Theravance, Inc. (Nasdaq: THRX ) announced today ... subset of,surgical-site-associated complicated skin and skin structure infections,(cSSSIs) ...
Cached Biology Technology:Kosan Biosciences to Present at the 2007 UBS Global Life Sciences Conference 2Astellas and Theravance Report Additional Telavancin Data at 47th Annual ICAAC 2Astellas and Theravance Report Additional Telavancin Data at 47th Annual ICAAC 3Astellas and Theravance Report Additional Telavancin Data at 47th Annual ICAAC 4Astellas and Theravance Report Additional Telavancin Data at 47th Annual ICAAC 5Astellas and Theravance Report Additional Telavancin Data at 47th Annual ICAAC 6
Mouse anti-Insulin-Like-3 Class: Antibody Product Group: Adipokine and Obesity related...
Rabbit polyclonal to Testosterone 19 ( Abpromise for all tested applications). Antigen: Testosterone 19 CME HSA (Human)...
Anti-Kusabira Orange Monoclonal Antibody Description: 100 g Research Focus: tag Storage: -20C Shipping Temperature: 4C...
Goat polyclonal to Als2 ( Abpromise for all tested applications). entrezGeneID: 57679 SwissProtID: Q96Q42...
Biology Products: